Skip to main content
. 2022 Jan 31;7(1):e007662. doi: 10.1136/bmjgh-2021-007662

Table 2.

Hearing aid studies and indicators

Study design Cohort Cross-sectional Mixed-methods Secondary cross-sectional Total
 N 1 9 1 14 25
 % 4% 36% 4% 56% 100%
Assessment approaches Clinical only Self-report only Functional only Clinical and self-report Clinical and functional Other combination Secondary sources (multiple)
 N 2 4 0 14 2 2 1 25
 % 8% 16% 0% 56% 8% 8% 4% 100%
Participants (N)* <500 500–999 1000–4999 5000–9999 10 000–24 999 >25 000 Not available
 N 3 1 11 2 3 4 1 25
 % 12% 4% 44% 8% 12% 16% 4% 100%
Age (years) included† Under 15 <15 to 85+ 15 to 85+ 40 to 85+ 65 to 85+ Over 85
 N 1 7 5 4 7 1 25
 % 4% 28% 20% 28% 28% 4% 100%
JBI score <7 7 8 9 10
 N 1 1 5 5 13 25
 % 4% 4% 20% 20% 52% 100%
Functioning difficulty or impairment definition Use of AP Reported activity limitations Clinical threshold Combination
 N 3 5 14 3 25
 % 12% 20% 56% 12% 100%
WHO Region AFR AMR EMR EUR SEAR WPR Global
 N 3 10 1 8 3 8 1 34
 % 9% 29% 3% 24% 9% 24% 3% 100%
AP access indicator Total need Met need Unmet need Undermet need Coverage Use Has AP
 N 7 1 17 0 2 26 9 62
 % 11% 2% 27% 0% 3% 42% 15% 100%
Indicator denominator Total with/using AP Total with need Total with functioning difficulty Total participants Total population
 N 1 20 15 24 2 62
 % 2% 32% 24% 39% 3% 100%

*Participants (N) ranged from 379 to 4 55 200 for this domain.

†Age group boundaries varied considerably by study; studies are sorted into categories that most closely represent their included age boundaries.

AFR, African Region; AMR, Region of the Americas; AP, assistive product; EMR, Eastern Mediterranean Region; EUR, European Region; JBI, Joanna Briggs Institute; SEAR, Southeast Asian Region; WPR, Western Pacific Region.